Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the... see more

TSX:EDT - Post Discussion

Spectral Medical Inc > SP off 30%+ since Seto became CEO
View:
Post by Domino55 on May 27, 2021 9:59am

SP off 30%+ since Seto became CEO

Despite many positive news releases we close red daily on minimal volume. The Kellum effect is completely wiped out.

why
Comment by vinoveritas on May 27, 2021 10:15am
Cuz much like the global covid BS we are facing, there is always someone with an agenda trying to make money off of and at the expense of others. But on that note, more people will die from the vaccines than ever would from the covid "flu". That should bode well for sepsis spikes in the coming years and shareholder value as a result.
Comment by Accountprince on May 27, 2021 10:21am
Dom perhaps ask why at the annual meeting.  At the start of 2020 we were at $0.80 per share and heading to $1 per share with an analyst report valuing us at $4 per share going much higher as we achieved FDA successes.  Life looked pretty good, Baxter arrived and we needed to move the Tigris ahead and get some approvals for Dialco.  While the meter for Tigris has only moved slightly ...more  
Comment by mercedesman on May 27, 2021 10:39am
Post of the month !  Hear hear ! I am looking for some signs of a possible mandate change as a result of the changing of the guard at the CEO level.  One might argue that, on paper at least, we are moving from a science driven CEO to a money/markets driven CEO.  On the other hand perhaps neither could make any "exposure moves" unless at the behest of the BoD?  We ...more  
Comment by Domino55 on May 28, 2021 2:16pm
MM-Have you seen any signs of a possible mandate change to date? I don't.   The Share Price still seems to flap in the wind untethered to the clinical milestones they continue to hit.
Comment by mercedesman on May 28, 2021 3:09pm
Nope. It still seems to be that "mums the word" ...despite lots of good things that could be embellished highlighted, summarized, disseminated, etc.  Info. that the market would likely eat up, while at the same time it might very well help to create demand for shares and therefor would be supportive of share price, and value discovery ...especially if the the right markets were ...more  
Comment by Accountprince on May 28, 2021 3:59pm
Dom - the share price doesn't flap aimlessly in the wind.  It's firmly nailed down at the level the manipulators want each day - today is 45 cent day. MM - I agree with you that we have a compelling story to tell.  I also agree with you that doing that would raise awareness, hope for the afflicted, tools for the health professionals and...a much higher share price for ...more  
Comment by Domino55 on May 27, 2021 1:00pm
AP- that is a worthy question in my opinion but the ticker EDT seems to operate in a separate universe with little relationship to the scientific and developmental progress itself. the Kellum hiring seemed to validate that science with a near doubling of the share price over the course of a few weeks. The Seto appointment then de coupled the share price again and we are where we are. Why did ...more  
Comment by Accountprince on May 27, 2021 2:01pm
You connect a direct line between our share price depreciation and the continuing promotion to CEO of the COO (formerly CFO).  You observe the market depreciating the share price as a direct result of this.  I think to be fair it's a question that should be posed at the upcoming shareholders meeting.  We shareholders have made our investment with the view this holding will ...more  
Comment by Domino55 on May 27, 2021 2:29pm
AP- I have never known Spectral to discuss their share price. It is treated as an almost independent entity unrelated to the company. The question may be asked but you are more likely to get blown off than get an explanation of why it trades in the mid 40 cent range. if they had an IR rep I'd ask them but they don't seem to have anybody.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities